Skip to main content
Top

Archives of Virology

Issue 4/1997

Content (17 Articles)

Five complete genomes of JC virus Type 3 from Africans and African Americans

H. T. Agostini, C. F. Ryschkewitsch, G. R. Brubaker, J. Shao, G. L. Stoner

Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3

M. Holberg-Petersen, A. K. M. Høgåsen, K. Høgåsen, T. G. Abrahamsen, M. Degré, H. Rollag

In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2)

R. Rochford, C. L. Miller, M. J. Cannon, K. M. Izumi, E. Kieff, R. Longnecker

Genetic and functional complementation of the HSV1 UL27 gene and gB glycoprotein by simian α-herpesvirus homologs

R. Eberle, B. Tanamachi, D. Black, E. L. Blewett, M. Ali, H. Openshaw, E. M. Cantin

Brief Report

Identification of ovine herpesvirus-2 infection in sheep

S. I. F. Baxter, A. Wiyono, I. Pow, H. W. Reid

Brief Report

Complete nucleotide sequence of the genome of a severe cherry isolate of apple chlorotic leaf spot trichovirus (ACLSV)

S. German-Retana, B. Bergey, R. P. Delbos, T. Candresse, J. Dunez

Brief Report

Field evaluation of chicken egg yolk immunoglobulins specific for bovine rotavirus in neonatal calves

M. Kuroki, M. Ohta, Y. Ikemori, F. C. Icatlo Jr., C. Kobayashi, H. Yokoyama, Y. Kodama

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine